Skip to content

Sharmin Ghaznavi

Department of Psychiatry, Center for the Neuroscience of Psychedelics, Massachusetts General Hospital, 149 13th St, Charlestown, MA, 02129, USA. sghaznavi@mgh.harvard.edu.

2 papers in the library · 8 citations · publishing 2024-2025

Papers

Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges.

Drugs May 1, 2025 Sharmin Ghaznavi, Sarah G Richter 6 citations

Recent research has revived interest in psychedelics as treatments for depression. This review examines studies on psilocybin, ayahuasca, DMT, and 5-Me-O DMT for treatment-resistant and major depression. It discusses the potential to expand depression treatment options based on available data, while also highlighting the difficulties and limitations of psychedelic research that complicate assessment of that potential.

Medical Uses and Adverse Effects of Psilocybin.

The primary care companion for CNS disorders May 28, 2024 Sharmin Ghaznavi, Lourdes M Bernardez, Theodore A Stern 2 citations

The Psychiatric Consultation Service at Massachusetts General Hospital provides care for medical and surgical inpatients who also have psychiatric symptoms or conditions. During twice-weekly rounds, clinicians discuss diagnosis and management of these complex patients. These discussions are the basis for reports intended to help clinicians working at the intersection of medicine and psychiatry.